{"id":2908,"date":"2024-12-17T13:56:33","date_gmt":"2024-12-17T12:56:33","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/"},"modified":"2024-12-17T13:56:34","modified_gmt":"2024-12-17T12:56:34","slug":"le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/","title":{"rendered":"Le traitement combin\u00e9 au xalnesiran s&rsquo;av\u00e8re prometteur chez les patients atteints d&rsquo;h\u00e9patite B"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2024\/combo-treatment-with-x.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2024\/combo-treatment-with-x.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Pour les patients atteints d&rsquo;une infection chronique par le virus de l&rsquo;h\u00e9patite B (VHB) avec suppression virologique avec un traitement par nucl\u00e9osides ou analogues nucl\u00e9otidiques (NA), le xaln\u00e9siran associ\u00e9 \u00e0 un immunomodulateur entra\u00eene une perte substantielle de l&rsquo;antig\u00e8ne de surface de l&rsquo;h\u00e9patite B (AgHBs), selon une \u00e9tude publi\u00e9e. dans le num\u00e9ro du 5 d\u00e9cembre du <i>Journal de m\u00e9decine de la Nouvelle-Angleterre<\/i>.<\/p>\n<p>Jinlin Hou, MD, de l&rsquo;h\u00f4pital Nanfang de Guangzhou, en Chine, et ses coll\u00e8gues ont men\u00e9 un essai multicentrique, randomis\u00e9 et contr\u00f4l\u00e9 de phase II impliquant des patients adultes atteints d&rsquo;une infection chronique par le VHB avec suppression virologique avec un traitement par NA pour examiner 48 semaines de traitement par xalnesiran 100 mg (groupe 1 ; 30 patients), xaln\u00e9siran 200 mg (groupe 2 ; 30 patients), xaln\u00e9siran 200 mg + ruzotolimod (groupe 3 ; 34 patients), xaln\u00e9siran 200 mg + interf\u00e9ron alfa-2a p\u00e9gyl\u00e9 180 \u00b5g (groupe 4 ; 30 patients), ou NA seul (groupe 5 ; 35 patients).<\/p>\n<p>Le principal crit\u00e8re d\u2019\u00e9valuation de l\u2019efficacit\u00e9 \u00e9tait la perte de l\u2019AgHBs 24 semaines apr\u00e8s la fin du traitement.<\/p>\n<p>Les chercheurs ont d\u00e9couvert qu&rsquo;un \u00e9v\u00e9nement majeur s&rsquo;est produit chez 7, 3, 12, 23 et 0\u00a0% des patients des groupes 1, 2, 3, 4 et 5, respectivement. Vingt-quatre semaines apr\u00e8s la fin du traitement, la s\u00e9roconversion AgHBs s\u2019est produite respectivement chez 3, 0, 3, 20 et 0\u00a0% des participants.<\/p>\n<p>Seuls les participants ayant un taux d\u2019AgHBs inf\u00e9rieur \u00e0 1\u00a0000 UI\/mL ont pr\u00e9sent\u00e9 une perte d\u2019AgHBs avec ou sans s\u00e9roconversion.<\/p>\n<p>\u00ab\u00a0Malgr\u00e9 les pourcentages \u00e9lev\u00e9s de participants pr\u00e9sentant une perte d&rsquo;AgHBs observ\u00e9s dans les groupes de th\u00e9rapie immunomodulatrice \u00e0 la fin du traitement, une \u00e9rosion de cette r\u00e9ponse a \u00e9t\u00e9 observ\u00e9e au cours de la p\u00e9riode de suivi\u00a0\u00bb, \u00e9crivent les auteurs.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pour les patients atteints d&rsquo;une infection chronique par le virus de l&rsquo;h\u00e9patite B (VHB) avec<\/p>\n","protected":false},"author":1,"featured_media":2909,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[282,56,2830,1606,49,616,437,1639,261,3135],"class_list":["post-2908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-atteints","tag-chez","tag-combine","tag-dhepatite","tag-les","tag-patients","tag-prometteur","tag-savere","tag-traitement","tag-xalnesiran","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Le traitement combin\u00e9 au xalnesiran s&#039;av\u00e8re prometteur chez les patients atteints d&#039;h\u00e9patite B - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le traitement combin\u00e9 au xalnesiran s&#039;av\u00e8re prometteur chez les patients atteints d&#039;h\u00e9patite B - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Pour les patients atteints d&rsquo;une infection chronique par le virus de l&rsquo;h\u00e9patite B (VHB) avec\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-17T12:56:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-17T12:56:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Le traitement combin\u00e9 au xalnesiran s&rsquo;av\u00e8re prometteur chez les patients atteints d&rsquo;h\u00e9patite B\",\"datePublished\":\"2024-12-17T12:56:33+00:00\",\"dateModified\":\"2024-12-17T12:56:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/\"},\"wordCount\":311,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg\",\"keywords\":[\"atteints\",\"chez\",\"combin\u00e9\",\"dh\u00e9patite\",\"Les\",\"patients\",\"prometteur\",\"sav\u00e8re\",\"traitement\",\"xalnesiran\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/\",\"name\":\"Le traitement combin\u00e9 au xalnesiran s'av\u00e8re prometteur chez les patients atteints d'h\u00e9patite B - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg\",\"datePublished\":\"2024-12-17T12:56:33+00:00\",\"dateModified\":\"2024-12-17T12:56:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Le traitement combin\u00e9 au xalnesiran s'av\u00e8re prometteur chez les patients atteints d'h\u00e9patite B\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le traitement combin\u00e9 au xalnesiran s&rsquo;av\u00e8re prometteur chez les patients atteints d&rsquo;h\u00e9patite B\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le traitement combin\u00e9 au xalnesiran s'av\u00e8re prometteur chez les patients atteints d'h\u00e9patite B - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/","og_locale":"fr_FR","og_type":"article","og_title":"Le traitement combin\u00e9 au xalnesiran s'av\u00e8re prometteur chez les patients atteints d'h\u00e9patite B - RVH-Synergie.org","og_description":"Pour les patients atteints d&rsquo;une infection chronique par le virus de l&rsquo;h\u00e9patite B (VHB) avec","og_url":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/","og_site_name":"RVH-Synergie","article_published_time":"2024-12-17T12:56:33+00:00","article_modified_time":"2024-12-17T12:56:34+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Le traitement combin\u00e9 au xalnesiran s&rsquo;av\u00e8re prometteur chez les patients atteints d&rsquo;h\u00e9patite B","datePublished":"2024-12-17T12:56:33+00:00","dateModified":"2024-12-17T12:56:34+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/"},"wordCount":311,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg","keywords":["atteints","chez","combin\u00e9","dh\u00e9patite","Les","patients","prometteur","sav\u00e8re","traitement","xalnesiran"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/","url":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/","name":"Le traitement combin\u00e9 au xalnesiran s'av\u00e8re prometteur chez les patients atteints d'h\u00e9patite B - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg","datePublished":"2024-12-17T12:56:33+00:00","dateModified":"2024-12-17T12:56:34+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1734440193_Le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients.jpg","width":1280,"height":853,"caption":"Le traitement combin\u00e9 au xalnesiran s'av\u00e8re prometteur chez les patients atteints d'h\u00e9patite B"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/le-traitement-combine-au-xalnesiran-savere-prometteur-chez-les-patients-atteints-dhepatite-b\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Le traitement combin\u00e9 au xalnesiran s&rsquo;av\u00e8re prometteur chez les patients atteints d&rsquo;h\u00e9patite B"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/2908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=2908"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/2908\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/2909"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=2908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=2908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=2908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}